1. Jivi, manufactured by Bayer, is a long-acting treatment for hemophilia A, a rare, genetic bleeding disorder. It is an injection for patients 12 years or older.
2. Imbruvica plus Rituxan, is a combination drug for the treatment of adult patients with Waldenstrom macroglobulinemia, a rare and incurable type of Non-Hodgkin lymphoma.
3. Merck received FDA approval for Delstrigo, a once-daily fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults.
4. Pifeltro is a non-nucleoside reverse transcriptase inhibitor, which is to be used in combination with other antiretroviral medicines for the treatment of HIV-1 infection in adults.
More articles on supply chain:
Hawaii blood bank makes urgent call for donors in wake of tropical storm
Infographic: OR Supply Chain- Let’s Talk about Change
A steroid to treat eye pain, a nontraditional OCD treatment & more: 4 latest FDA approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
